Dr. David Rudolph
CEO & Shareholder
-
Coordinates and plans research activities.
-
Develops and refines the company strategy.
-
Oversees development, synthesis, and chemical analysis of (Dual)-Hybrid-NP.
-
Manages communication with external consultants.
-
Represents the company and presents results to the public and investors.
Biosketch
Dr. David Rudolph, our managing director, completed his PhD in Chemistry at the Karlsruhe Institute of Technology (KIT) under supervision of Prof. Claus Feldmann, focusing on nanoparticle-based drug-delivery systems and inventing the Dual-Hybrid-NP. During his doctorate, he collaborated with Prof. Frauke Alves, whom he has known for a long time. Since the founding of NanoDrug Delivery GmbH, David has been motivated by the potential to help patients with his research and enjoys learning about business and industrial development. He particularly enjoys guiding the transition from basic research to practical application.
Contact
Driven by the challenge of transforming research into solutions that truly help patients.
Let’s connect to discuss innovation.